Abstract
Adolescent women with epilepsy have special characteristics that make their treatment unique and individualized. At this age the principal primary epilepsy syndromes appear and need treatment for long periods time. The adverse reactions and interactions of the antiepileptic drugs would affect the reproductive cycles with secondary infertility, induce hormonal disequilibrium (polycystic ovary syndrome), osteoporosis, weight gain, esthetical changes, etc. These alterations have a considerable impact in the adolescence. Spite of these problems is possible to treat this kind of patients with the opportunity of a normal life.
References
Diamantopoulos N, Crumrine PK. The effect of puberty on the course of epilepsy. Arch Neurol 1986; 43: 873-6.
Medina Malo C, Morillo LE, Arango GJ. Aspectos Clínicos y clasificación, En: Medina Malo C. Epilepsia, aspectos clínicos y psicosociales, Editorial Médica Panamericana, 2004.
Wheless JW, Kim HL. Adolescent seizures and epilepsy syndromes. Epilepsia 2002; 43 Suppl 3: 33-52.
French JA, Williamson PD, Thadani VM, et al. Characteristics of medial temporal lobe epilepsy:results of history and physical examination. Ann Neurol 1993; 34: 774-780.
Serrano-Castro PJ, Sánchez-Alvarez JC, García Gómez T. Esclerosis Mesial Temporal (II): Manifestaciones Clínicas y estudios Complementarios. Rev Neurol 1988; 26: 592-597.
Wiebe S., Blume W. T., Girvin J. P., Eliasziw M. The Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. N Engl J Med 2001; 345: 311-318.
Montalenti E, Imperiale D, Rovera A, et al. Clinical features, EEG findings and diagnostic pitfalls in juvenile myoclonic epilepsy: a series of 63 patients. J Neurol Sci 2001; 184: 65-70.
Genton P, Gelisse P. Juvenile myoclonic epilepsy. Arch Neurol 2001; 58: 1487-1490.
Greenberg DA, Durner M, Keddache M, et al. Reproducibility and complications in gene searches: linkage on chromosome 6, heterogeneity, association, and maternal inheritance in juvenile myoclonic epilepsy. Am J Hum Genet 2000; 66: 508-516.
Lombroso CT. Consistent EEG focalities detected in subjects with primary generalized epilepsies monitored for two decades. Epilepsia 1997; 38: 797-812.
Dhanuka AK, Jain BK, Daljit S, et al. Juvenile myoclonic epilepsy: a clinical and sleep EEG study. Seizure 2001; 10: 374-8.
Panayiotopoulos CP, Obeid T, Tañan AR. Juvenile myoclonic epilepsy: a 5 year prospective study. Epilepsia 1994; 35: 285-296.
Erikkson AS, Negardh A, Hoppu K., The efficacy of Lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized double blind, cross over study. Epilepsia 1998; 39(5): 495-501.
Kwan P, Sander JW. The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry 2004; 75: 1376-1381.
Reutens DC, Berkovic SF. Idiopathic generalized epilepsy of adolescence:are the syndromes clinically distinct? Neurology 1995; 45: 1469-76.
Janz D. The idiopathic generalized epilepsies of adolescence with childhood and juvenile age of onset. Epilepsia 1997; 38: 4-11.
Greenberg DA, Durner M, Resor S, et al. The genetics of idiopathic generalized epilepsies of adolescent onset: differences between juvenile myoclonic epilepsy and epilepsy with random grand mal and with awakening grand mal. Neurology 1995; 45: 942-946.
Janz D. Epilepsy with grand mal on awakening and sleep-waking cycle. Clin Neurophysiol 2000; 111(suppl 2): S103-110.
Berkovic SF, So NK, Andermann F. Progressive myoclonus epilepsies: clinical and neurophysiological diagnosis. J Clin Neurophysiol 1991; 8: 261-274.
Lizcano LA. Mujer y Epilepsia. En: Medina MaloC. Epilepsia, aspectos clínicos y psicosociales, Editorial Médica Panamericana, 2004.
Morrell MJ. Epilepsy in women. Am Fam Physician 2002; 66: 1489-1494.
Practice parameter management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. 1998.
Kwan P, Brodie MJ.Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-319.
Penovich PE, Eck KE, Economou VV. Recommendations for the care of women with epilepsy. Cleve Clin J Med 2004; 71 (Suppl 2): S49-57.
Isojarvi JI, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllyla VV. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996; 39(5): 579-584.
Corman CL, Leung NM, Guberman AH. Weight gain in epileptic patients during treatment with valproic acid: a retrospective study. Can J Neurol Sci 1997; 24: 240-244.
Pack AM, Morrell MJ, Randall A, et al. Markers of general bone function, bone formation and bone resorption in women with epilepsy on antiepileptic drug monotherapy. Neurology 2003; 60 (Suppl 1): A432. Abstract.
Morrell MJ, Giudice J, Flynn KL, et al. Predictors of ovulatory failure in women with epilepsy. Ann Neurol 2002; 52: 704-711.
Schupf N, Ottman R. Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: social and biologic influences. Epilepsia 1994; 35: 750-756.
Honein MN, Paulozzi LJ, Matthews TJ, et al. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001; 285: 2981-2986.
Kanner A, Rivas J. Depressive Disorders in Epilepsy. Neurology 1999; 53 (Suppl 2): S26-S32.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.